Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer
出版年份 2021 全文链接
标题
Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-21
DOI
10.1186/s13046-021-02010-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis
- (2021) Chao Cheng et al. Molecular Therapy-Methods & Clinical Development
- Targeting Ubiquitin–Proteasome System With Copper Complexes for Cancer Therapy
- (2021) Xin Chen et al. Frontiers in Molecular Biosciences
- Exosomes mediate intercellular transfer of non‐autonomous tolerance to proteasome inhibitors in mixed‐lineage leukemia
- (2020) Maolin Ge et al. CANCER SCIENCE
- Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
- (2020) Eric K. Rowinsky et al. INVESTIGATIONAL NEW DRUGS
- Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
- (2020) Meirong Zang et al. Oncogenesis
- Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence
- (2020) Deniz Bakkalci et al. Journal of Global Health
- A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma
- (2020) Wen Liu et al. ADVANCES IN THERAPY
- ANXA1 binds and stabilizes EphA2 to promote nasopharyngeal carcinoma growth and metastasis
- (2020) Juan Feng et al. CANCER RESEARCH
- S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1
- (2020) Dong-Fang Meng et al. ONCOGENE
- Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma
- (2020) Mingdan Deng et al. Cancers
- The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases
- (2020) Gizem Celebi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection
- (2020) Benjamin Fournier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
- (2020) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
- (2019) Kwai Fung Hui et al. Frontiers in Oncology
- Mitochondrial metabolism promotes adaptation to proteotoxic stress
- (2019) Peter Tsvetkov et al. Nature Chemical Biology
- HLA regions contribute to the ethnicity bias of EBV ‐associated NPC in higher‐incidence populations
- (2019) Nabanita Roy Chattopadhyay et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
- (2019) Zixi Liang et al. Cell Death & Disease
- Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression Without Virion Production
- (2019) Jaeyeun Lee et al. JOURNAL OF VIROLOGY
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies
- (2019) Filipa Lynce et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Curcumin Inhibits Proliferation of Epstein–Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression
- (2019) Limei Liu et al. Biomed Research International
- Monalizumab: inhibiting the novel immune checkpoint NKG2A
- (2019) Thorbald van Hall et al. Journal for ImmunoTherapy of Cancer
- Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
- (2019) Rob J. A. Verhoeven et al. Frontiers in Oncology
- Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma
- (2018) Noppadol Larbcharoensub et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
- (2018) Hailong Ma et al. BRITISH JOURNAL OF CANCER
- Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment
- (2018) Takeharu Ono et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study
- (2018) Ya-Qin Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Phylogenetic comparison of Epstein-Barr virus genomes
- (2018) Su Jin Choi et al. JOURNAL OF MICROBIOLOGY
- NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
- (2018) A. Dimitrios Colevas et al. Journal of the National Comprehensive Cancer Network
- The Unfolded Protein Response and Cell Fate Control
- (2018) Claudio Hetz et al. MOLECULAR CELL
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Expression of Cullin 3 in Nasopharyngeal Carcinoma and Knockdown Inhibits Proliferation and Invasion
- (2018) Ruifang Zeng et al. ONCOLOGY RESEARCH
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- Expression and purification of a rapidly degraded protein, TMEM8B-a, in mammalian cell line
- (2018) Li Wang et al. PROTEIN EXPRESSION AND PURIFICATION
- A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study
- (2018) Dong-Fang Meng et al. Journal of Cancer
- Latent Membrane Protein 1 of Epstein–Barr Virus Promotes RIG-I Degradation Mediated by Proteasome Pathway
- (2018) Chongfeng Xu et al. Frontiers in Immunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The addition of pretreatment plasma Epstein-Barr virus DNA into the 8th edition of nasopharyngeal cancer TNM stage classification
- (2018) Victor Ho-Fun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells
- (2018) Heng Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
- (2018) Wenfeng Fang et al. LANCET ONCOLOGY
- Expression and clinical significance of S100 family genes in patients with melanoma
- (2018) Xiong Tingfeng et al. MELANOMA RESEARCH
- Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation
- (2018) Hao-Jiong Zhang et al. PLoS Pathogens
- A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
- (2018) Jillian A. Bristol et al. PLoS Pathogens
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent advances in metal nanoparticles in cancer therapy
- (2017) Ankush Sharma et al. JOURNAL OF DRUG TARGETING
- West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5
- (2017) Hong-Lei Zhang et al. JOURNAL OF VIROLOGY
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- Recent Patents on Proteasome Inhibitors of Natural Origin
- (2017) Daniela Correia da Silva et al. Recent Patents on Anti-Cancer Drug Discovery
- From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
- (2017) Thomas Efferth SEMINARS IN CANCER BIOLOGY
- The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy
- (2017) Yuanbing Wu et al. Translational Research
- Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors
- (2017) Kwai Hui et al. Viruses-Basel
- EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
- (2017) Leah Fitzsimmons et al. Viruses-Basel
- Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
- (2017) Yvonne Y Li et al. Nature Communications
- Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes
- (2017) Ruda de Luna Almeida Santos et al. Nature Communications
- Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer
- (2017) Sanaz Taromi et al. Oncotarget
- The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I
- (2017) Chunyuan Zhao et al. Cell Reports
- RIG-I: a multifunctional protein beyond a pattern recognition receptor
- (2017) Xiao-xiao Xu et al. Protein & Cell
- Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes
- (2017) Qian Zhu et al. OncoImmunology
- Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells
- (2017) Murat R. Gainullin et al. Scientific Reports
- Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome
- (2016) Izidor Sosič et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal
- (2016) Hugo Sousa et al. IMMUNOBIOLOGY
- The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells
- (2016) Lindsey M. Hutt-Fletcher JOURNAL OF VIROLOGY
- Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
- (2016) G P Soriano et al. LEUKEMIA
- VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal
- (2016) Prabhakar Bastola et al. Molecular Oncology
- Protein misfolding in the endoplasmic reticulum as a conduit to human disease
- (2016) Miao Wang et al. NATURE
- Are HLA-E*0103 alleles predictive markers for nasopharyngeal cancer risk?
- (2016) Hayet Douik et al. PATHOLOGY RESEARCH AND PRACTICE
- Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
- (2016) Hong Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 2.3 A resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition
- (2016) S. Banerjee et al. SCIENCE
- Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
- (2016) Dominik Dytfeld et al. Oncotarget
- Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation
- (2016) Guan-Min Jiang et al. Cancer Immunology Research
- Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing
- (2016) Lijuan Hu et al. Frontiers of Medicine
- Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study
- (2016) Anna Maria Santoro et al. Scientific Reports
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2015) Chungyee Leung-Hagesteijn et al. CANCER CELL
- O6-methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma
- (2015) Shang Hung Chen et al. INTERNATIONAL JOURNAL OF CANCER
- A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group (NCCTG)-N0321
- (2015) Yujie Zhao et al. Journal of Thoracic Oncology
- Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
- (2015) Pierre Blanchard et al. LANCET ONCOLOGY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
- (2015) Wenfeng Fang et al. Oncotarget
- Recurrent Overexpression of c-IAP2 in EBV-Associated Nasopharyngeal Carcinomas: Critical Role in Resistance to Toll-like Receptor 3-Mediated Apoptosis
- (2015) Luc Friboulet et al. NEOPLASIA
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- HLA-ASNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese
- (2014) Yoon-Ming Chin et al. INTERNATIONAL JOURNAL OF CANCER
- SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells
- (2014) X Zhou et al. ONCOGENE
- Etiological factors of nasopharyngeal carcinoma
- (2014) Sai Wah Tsao et al. ORAL ONCOLOGY
- Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of Ch
- (2013) Yong Chen et al. CANCER
- Induction of Siglec-G by RNA Viruses Inhibits the Innate Immune Response by Promoting RIG-I Degradation
- (2013) Weilin Chen et al. CELL
- From Bortezomib to other Inhibitors of the Proteasome and Beyond
- (2013) Daniela Buac et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer
- (2013) Tsukasa Seya et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer
- (2013) H. Chen et al. MOLECULAR CANCER RESEARCH
- Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein-Barr Virus
- (2013) K. F. Hui et al. MOLECULAR CANCER THERAPEUTICS
- Switching of EBV cycles between latent and lytic states
- (2013) Takayuki Murata et al. REVIEWS IN MEDICAL VIROLOGY
- Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma
- (2012) Y. Pan et al. CANCER RESEARCH
- Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of
- (2012) Jill Gilbert et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
- (2012) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells
- (2012) T. Eichhorn et al. Molecular BioSystems
- Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma
- (2012) Zhen Liu et al. PROTEOMICS
- Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000–2011
- (2012) Allan Hildesheim et al. SEMINARS IN CANCER BIOLOGY
- The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
- (2012) Christopher W. Dawson et al. SEMINARS IN CANCER BIOLOGY
- Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial
- (2011) Primo N. Lara et al. Clinical Lung Cancer
- S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest
- (2011) Dipak Sapkota et al. ORAL ONCOLOGY
- Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells
- (2011) Pok Man Hau et al. PLoS One
- Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
- (2011) Zhen Liu et al. PLoS One
- Nasopharyngeal carcinoma
- (2010) A. T. C. Chan ANNALS OF ONCOLOGY
- Chromosomal alterations in Malaysian patients with nasopharyngeal carcinoma analyzed by comparative genomic hybridization
- (2010) M.N. Natasya Naili et al. CANCER GENETICS AND CYTOGENETICS
- Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?
- (2010) Philip Cohen et al. CELL
- Targeting the Undruggable Proteome: The Small Molecules of My Dreams
- (2010) Craig M. Crews CHEMISTRY & BIOLOGY
- The p38 Signaling Pathway Upregulates Expression of the Epstein-Barr Virus LMP1 Oncogene
- (2010) P. Johansson et al. JOURNAL OF VIROLOGY
- A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
- (2010) Jin-Xin Bei et al. NATURE GENETICS
- Immunogenicity and efficacy of a DNA vaccine encoding a human anti-idiotype single chain antibody against nasopharyngeal carcinoma
- (2010) Chen Luo et al. VACCINE
- The LMP1 Promoter Can Be Transactivated Directly by NF- B
- (2009) C. Demetriades et al. JOURNAL OF VIROLOGY
- Tyrosine phosphorylation of cofilin at Y68 by v-Src leads to its degradation through ubiquitin–proteasome pathway
- (2009) Y Yoo et al. ONCOGENE
- Copper-Triggered Aggregation of Ubiquitin
- (2009) Fabio Arnesano et al. PLoS One
- Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients
- (2008) C. U. Louis et al. BLOOD
- Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
- (2008) Weiyi Fang et al. Journal of Translational Medicine
- Nuclear Factor- B Binds to the Epstein-Barr Virus LMP1 Promoter and Upregulates Its Expression
- (2008) P. Johansson et al. JOURNAL OF VIROLOGY
- Epstein–Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling
- (2008) M Samanta et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now